{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:18:03Z","timestamp":1768825083141,"version":"3.49.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"French Ministry of Health"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184441","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T13:40:46Z","timestamp":1506951646000},"page":"e0184441","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-4261","authenticated-orcid":true,"given":"Sophie","family":"Grabar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Selinger-Leneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Abgrall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pialoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"issue":"2","key":"ref1","first-page":"149","article-title":"A systematic review of definitions of extreme phenotypes of HIV control and progression","volume":"28","author":"D Gurdasani","year":"2014"},{"issue":"15","key":"ref2","first-page":"2451","article-title":"Natural history of HIV-control since seroconversion","volume":"27","author":"Y Madec","year":"2013"},{"issue":"7","key":"ref3","first-page":"e0131922","article-title":"Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study","volume":"10","author":"N Noel","year":"2015"},{"issue":"8","key":"ref4","first-page":"1209","article-title":"Rate and predictors of progression in elite and viremic HIV-1 controllers","volume":"30","author":"A Leon","year":"2016"},{"issue":"2","key":"ref5","first-page":"e29844","article-title":"Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988\u20132010","volume":"7","author":"S Mandalia"},{"issue":"1","key":"ref6","first-page":"e41","article-title":"Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study","volume":"1","author":"JJ van der Helm","year":"2014"},{"issue":"4","key":"ref7","first-page":"407","article-title":"Disease Progression in HIV-1-Infected Viremic Controllers","volume":"61","author":"KC Groves","year":"2012"},{"issue":"11","key":"ref8","first-page":"1714","article-title":"Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study","volume":"200","author":"JF Okulicz","year":"2009"},{"issue":"4","key":"ref9","first-page":"e0173893","article-title":"Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers","volume":"12","author":"F Chereau","year":"2017"},{"issue":"11","key":"ref10","first-page":"1689","article-title":"Antiretroviral therapy in the elite controller: justified or premature?","volume":"211","author":"MY Karris","year":"2015"},{"issue":"9","key":"ref11","first-page":"1163","article-title":"Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV","volume":"23","author":"S Grabar","year":"2009"},{"issue":"5","key":"ref12","first-page":"1425","article-title":"Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)","volume":"43","author":"M Mary-Krause","year":"2014"},{"issue":"446","key":"ref13","first-page":"496","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"J Fine","year":"1999"},{"issue":"4","key":"ref14","first-page":"955","article-title":"Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers","volume":"118","author":"A Saez-Cirion","year":"2011"},{"issue":"10","key":"ref15","first-page":"e1003691","article-title":"Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers","volume":"9","author":"H Hatano","year":"2013"},{"issue":"1","key":"ref16","first-page":"e85516","article-title":"Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration","volume":"9","author":"F Boufassa","year":"2014"},{"issue":"9","key":"ref17","first-page":"795","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"JD Lundgren","year":"2015"},{"key":"ref18","unstructured":"Molina J, Grund B, Gordin F, Williams I, Schechter M, Losso M, et al. Who Benefited Most From Immediate Treatment in START. A Subgroup Analysis. In: 21st International AIDS Conference Durban, South Africa; 2016."},{"issue":"11","key":"ref19","first-page":"1692","article-title":"Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection","volume":"211","author":"TA Crowell","year":"2015"},{"issue":"18","key":"ref20","first-page":"2409","article-title":"Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers","volume":"26","author":"F Pereyra","year":"2012"},{"issue":"1","key":"ref21","first-page":"20524","article-title":"Hospitalizations among HIV controllers and persons with medically controlled HIV in the U","volume":"19","author":"TA Crowell","year":"2016"},{"issue":"11","key":"ref22","first-page":"1483","article-title":"Identity, Representations, and Beliefs: HIV Controllers Living on the Frontier of Good Health and Illness","volume":"26","author":"M Preau","year":"2016"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:11:37Z","timestamp":1540339897000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184441"}},"subtitle":[],"editor":[{"given":"Cristian","family":"Apetrei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184441","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]}}}